238 results on '"Scheetz, Marc"'
Search Results
2. Antimicrobial Therapeutic Drug Monitoring in critically ill adult patients -an international perspective on access, utilisation, and barriers.
3. Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections
4. Meta-analysis on safety of standard vs prolonged infusion of beta-lactams
5. Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
6. Individual meropenem epithelial lining fluid and plasma PK/PD target attainment
7. 535: IMPACT OF VARIOUS EGFR EQUATIONS ON THE PHARMACOKINETICS OF MEROPENEM IN CRITICALLY ILL ADULTS
8. 2560. Individual Meropenem Epithelial Lining Fluid and Plasma PK/PD Target Attainment in Patients with Pneumonia
9. 2946. Comparative Pharmacokinetics and Pharmacodynamics of Cefadroxil and Cephalexin for Pediatric Musculoskeletal Infections
10. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents
11. Preclinical assessment of nirmatrelvir penetration into cerebrospinal fluid and central nervous system cells and tissues
12. Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model
13. Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
14. Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study
15. Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital
16. A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalised patients
17. A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurement
18. Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study
19. Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model
20. Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model
21. Flucloxacillin worsens while imipenem-cilastatin protects against vancomycin induced kidney injury in a translational rat model
22. Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation
23. Nephrotoxin Stewardship Alongside Antimicrobial Stewardship
24. Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity
25. 743. Implementation of Beta-Lactam Therapeutic Drug Monitoring Programs in the Critically Ill: A Multicenter Mixed-Methods Study
26. 967. Safety Outcomes of a Hospital-wide β-Lactam Graded Challenge Allergy Protocol
27. Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
28. Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
29. Impact of vancomycin loading doses and dose escalation on glomerular function and kidney injury biomarkers in a translational rat model
30. Blood Biomarkers and Metabolomic Profiling for the Early Diagnosis of Vancomycin-Associated Acute Kidney Injury: A Systematic Review and Meta-Analysis of Experimental Studies
31. Urinary Metabolomics From a Dose-Fractionated Polymyxin B Rat Model of Acute Kidney Injury
32. Clinical Pharmacokinetics and Pharmacodynamics of Cefepime
33. Does calculation method matter for targeting vancomycin area under the curve?
34. Hippocampal Concentrations Drive Seizures in a Rat Model for Cefepime-induced Neurotoxicity
35. In Vitro Nephrotoxicity and Permeation of Vancomycin Hydrochloride Loaded Liposomes
36. A translational rat model to assess glomerular function changes with vancomycin
37. Vancomycin Pharmacokinetics in a Pregnancy Rat Model
38. Glomerular Function and Urinary Biomarker Changes between Vancomycin and Vancomycin plus Piperacillin-Tazobactam in a Translational Rat Model
39. Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics
40. Implementing a Continuous or Prolonged Infusion Beta-Lactam Program in the Hospital Setting
41. Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
42. Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study
43. Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients
44. Glomerular function and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model
45. 1090. Does calculation method matter for targeting vancomycin AUC?
46. Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships
47. Precision dosing of vancomycin: in defence of AUC-guided therapy in children
48. Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum
49. Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?
50. Urinary Metabolomics from a Dose-Fractionated Polymyxin B Rat Model of Acute Kidney Injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.